Publication | Closed Access

An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities

MechanobiologyCardiac MuscleCardiomyopathyHeart FailureEngineeringCardiovascular DiseasePhysiologyElectrophysiologyCardiovascular PhysiologyBiomedical EngineeringImpedance-based ApproachMedicineVivo Cardiotox LiabilitiesCardiologyCardiac MechanicVitro Prediction